Completely agree!! The register should be much tighter as well, and with clinical trials progressing to the final stages we are in a very exciting time for the company and shareholders. 2024 is poised to be a big year!
Cheers
EMvision Research Notes, page-2227
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.91 |
Change
0.025(1.33%) |
Mkt cap ! $163.1M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.00 | $1.91 | $28.37K | 14.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 967 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 1815 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.92 |
Change
0.025 ( 0.26 %) |
||||
| Open | High | Low | Volume | ||
| $1.99 | $2.00 | $1.92 | 1292 | ||
| Last updated 15.56pm 14/06/2024 ? | |||||
| EMV (ASX) Chart |